These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23463468)

  • 1. Successful large-volume cerebrospinal fluid aspiration for an accidental overdose of intrathecal cytarabine.
    Makar G; Al-Zubaidi M; Amar S; Feiz-Erfan I; Mehta D
    Med Oncol; 2013 Jun; 30(2):525. PubMed ID: 23463468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of inadvertent administration of overdose of intrathecal Cytarabine in a pediatric patient.
    Al Omar S; Amayiri N; Madanat F
    J Oncol Pharm Pract; 2015 Oct; 21(5):384-7. PubMed ID: 24781453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of two cases on the same day of intrathecal methotrexate overdose using cerebrospinal fluid exchange and intrathecal instillation of carboxypeptidase-G2.
    Wormdal OM; Flægstad T; Stokland T
    Pediatr Hematol Oncol; 2018; 35(5-6):350-354. PubMed ID: 30672361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accidental overdose of intrathecal cytarabine in children.
    Thienprayoon R; Heym KM; Pelfrey L; Bowers DC
    Ann Pharmacother; 2013 May; 47(5):e24. PubMed ID: 23606548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exchange of cerebrospinal fluid in accidental intrathecal overdose of cytarabine.
    Lafolie P; Liliemark J; Björk O; Aman J; Wranne L; Peterson C
    Med Toxicol Adverse Drug Exp; 1988; 3(3):248-52. PubMed ID: 3165155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC; Balis FM; Shalabi A; Boron M; O'Brien M; Cole DE; Jayaprakash N; Ivy P; Castle V; Muraszko K; Moertel CL; Trueworthy R; Hermann RC; Moussa A; Hinton S; Reaman G; Poplack D; Adamson PC
    J Natl Cancer Inst; 2004 Oct; 96(20):1557-9. PubMed ID: 15494606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal leucovorin after intrathecal methotrexate overdose.
    Jardine LF; Ingram LC; Bleyer WA
    J Pediatr Hematol Oncol; 1996 Aug; 18(3):302-4. PubMed ID: 8689347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.
    O'Marcaigh AS; Johnson CM; Smithson WA; Patterson MC; Widemann BC; Adamson PC; McManus MJ
    Mayo Clin Proc; 1996 Feb; 71(2):161-5. PubMed ID: 8577190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two cases.
    Jakobson AM; Kreuger A; Mortimer O; Henningsson S; Seidel H; Moe PJ
    Acta Paediatr; 1992 Apr; 81(4):359-61. PubMed ID: 1606401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal methotrexate overdose.
    Lee AC; Wong KW; Fong KW; So KT
    Acta Paediatr; 1997 Apr; 86(4):434-7. PubMed ID: 9174236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed recognition of intrathecal methotrexate overdose.
    Malbora B; Ozyurek E; Kocum AI; Ozbek N
    J Pediatr Hematol Oncol; 2009 May; 31(5):352-4. PubMed ID: 19415018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of intrathecal methotrexate overdose with folinic acid rescue: a case report.
    Riva L; Conter V; Rizzari C; Jankovic M; Sala A; Milani M
    Acta Paediatr; 1999 Jul; 88(7):780-2. PubMed ID: 10447141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Treatment of accidental intrathecal methotrexate overdose.
    Gosselin S; Isbister GK
    J Natl Cancer Inst; 2005 Apr; 97(8):609-10; author reply 610-1. PubMed ID: 15840887
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal leukovorin after intrathecal methotrexate overdose.
    Trinkle R; Wu JK
    J Pediatr Hematol Oncol; 1997; 19(3):267-9. PubMed ID: 9201155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases].
    Cartier R L; Parra V J; Puga B; Cardemil D
    Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.
    Brion A; Legrand F; Larosa F; Schillinger F; Garnache-Ottou F; Helias P; Fontan J; Heczko M; Delaby P; Daguindau E; Vuillier J; Chauchet A; Deconinck E
    Invest New Drugs; 2012 Aug; 30(4):1697-702. PubMed ID: 21229289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.
    Benesch M; Sovinz P; Krammer B; Lackner H; Mann G; Schwinger W; Gadner H; Urban C
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):222-6. PubMed ID: 17414563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.
    Peyrl A; Sauermann R; Traunmueller F; Azizi AA; Gruber-Olipitz M; Gupper A; Slavc I
    Clin Pharmacokinet; 2009; 48(4):265-71. PubMed ID: 19492871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
    Jahn F; Jordan K; Behlendorf T; Globig C; Schmoll HJ; Müller-Tidow C; Jordan B
    Oncology; 2015; 89(3):137-42. PubMed ID: 25791073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.
    Hilgendorf I; Wolff D; Junghanss C; Kahl C; Leithaeuser M; Steiner B; Casper J; Freund M
    Ann Hematol; 2008 Dec; 87(12):1009-12. PubMed ID: 18704421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.